PubMed COVID-19 Clinical Care

新型冠状病毒感染（coronavirus disease 2019，COVID-19）是由2型严重急性呼吸综合征冠状病毒（severe acute respiratory syndrome coronavirus 2，SARS-CoV-2）引起的疾病。COVID-19的临床症状多样，其中患者出现味觉障碍的报道越来越多。本文回顾了现有的国内外相关文献，对COVID-19患者味觉障碍的流行病学、潜在机制及治疗方式进行系统性归纳总结。味觉障碍的致病机制假说较多，具体机制尚不明确。目前缺乏有效的治疗方法

The advent of single-cell RNA sequencing (scRNA-seq) technologies has enabled gene expression profiling at the single-cell resolution, thereby enabling the quantification and comparison of transcriptional variability among individual cells. Although

No abstract

CONCLUSIONS: People with SCI have experienced living difficulties during the COVID-19 pandemic. Of particular importance, no routine healthcare access and more health conditions are related to more difficulties obtaining both daily necessities and

CONCLUSIONS: For former patients who were admitted to an intensive care unit after a diagnosis of COVID-19, memories caused considerable distress, which were similar to other intensive care patientś experiences, before the pandemic. Emotion-focused

No abstract

No abstract

Twenty neglected tropical diseases (NTDs) are currently prioritised by the World Health Organization for eradication, elimination as a public health problem, elimination of transmission or control by 2030. This issue celebrates progress made since

Wearing a facemask remains a pivotal strategy to prevent SARS-CoV-2 infection even after vaccination, but one of the possible costs of this protection is that it may interfere with the ability to read emotion in facial expressions. We explored the

The U.S. Food and Drug Administration authorized use of mRNA COVID-19 bivalent booster vaccines on August 31, 2022. Currently, CDC's clinical guidance states that COVID-19 and other vaccines may be administered simultaneously. At time of